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Background & objectives: Data on the burden of tuberculosis (TB) in India are vital for
programme planners to plan the resource requirements and for monitoring the nation-wide TB
control programme. There was a need to revise the earlier estimate on the burden of TB in India
based on the increase in population and current epidemiological data. This study estimates the
burden of disease for the year 2000 based on recent prevalence of TB and annual risk of
tuberculosis infection (ARTI) estimates.
Methods: Data on prevalence generated among adults by the Tuberculosis Research Centre (TRC),
Chennai, among children by National Tuberculosis Institute (NTI), Bangalore, and the ARTI
estimates from the nation-wide sample survey by NTI and TRC were used for the estimation.
The prevalence of disease corresponding to 1 per cent ARTI was extrapolated to different parts
of the country using the estimates of ARTI and the population in those areas and added together
to get the total cases. Abacillary cases that required treatment were estimated from X-ray
abnormals. The estimates of bacillary, abacillary and extrapulmonary cases were then combined
to get the national burden.
Results: The estimated number of bacillary cases was 3.8 million (95% CI: 2.8 - 4.7).  The
number of abacillary cases was estimated to be 3.9 million and that for extrapulmonary cases
was 0.8 million giving a total burden of 8.5 million (95% CI: 6.3-10.4) for 2000.
Interpretation & conclusion: The present estimate differs from the earlier estimates because we
have included the disease burden of X-ray cases that are likely to breakdown to bacillary cases
in a one year period, and extrapulmonary TB cases. The current estimates provided baseline
information for advocacy and planning resource allocation for TB control activities. Also, these
estimates can be compared with that in future years to measure the long term impact of TB
control activities in India.
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India, with its population of over 1000 million, is
estimated to account for nearly 30 per cent of the
global tuberculosis burden1. Tuberculosis (TB)
continues to be a major health problem in India
because of its high mortality and morbidity2. Data on
the burden of tuberculosis are vital for programme
planners in order to calculate the resource
requirements, and monitor the nation-wide TB control
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programme. The National Tuberculosis Control
Programme (NTP) was implemented in 1962.
However, when reviewed in 1992, after three decades
of implementation, the NTP was shown to have made
no epidemiological impact, mainly due to poor case
finding and low treatment completion rates3. As a
result, the Government of India (GoI) in 1993
developed the Revised National Tuberculosis Control
Programme (RNTCP) based on the internationally
recommended Directly Observed Treatment – Short
course (DOTS) strategy. Since 1998, the RNTCP has
undergone a rapid expansion, and by November 2004
covered a population of over 920 million4. Based on
the findings of the National Sample Survey (NSS)
conducted by Indian Council of Medical Research
(ICMR) during 1955-585, an estimate of the burden
of TB in India of 3.5 million bacillary cases and 14
million persons with abnormal chest X-rays suggestive
of tuberculosis with negative sputum (hereafter,
referred to as X-ray abnormals) was made at the time
of introduction of RNTCP in 19976. In 2000, an expert
committee convened by the GoI, analyzed the data
available from comparable studies, and estimated the
burden in the year as 4.32 million bacillary cases and
11 million X-ray abnormals (unpublished data). The
estimated X-ray abnormals reported could be an
overestimate because the non-specific shadows in the
X-rays could be due to various other diseases and
would also include patients who would never develop
TB. Also, extrapulmonary cases were not included in
these estimates. The population of India has increased
substantially after these estimates were obtained.
Considering the above points, it was thought necessary
to revise this estimate using the current
epidemiological data available. Further, there is a need
to estimate, as accurately as possible, the burden of
TB at the start of the RNTCP in order to assess the
impact of the programme as it is implemented and for
the logistic purposes. The present study was
undertaken to estimate the current disease burden in
India for the year 2000 based on recent prevalence of
disease and annual risk of tuberculosis infection
(ARTI) estimates7-9.
Material & Methods
This report summarizes the estimation of burden
of disease based on recent prevalence and ARTI
estimates generated by Tuberculosis Research Centre
(TRC), Chennai, disease survey among children by
National Tuberculosis Institute (NTI), Bangalore and
the ARTI estimates from the nation-wide sample
survey by NTI and TRC7-9. For the estimation of the
burden of tuberculosis, the following definitions were
used.
Bacillary case: (i) Sputum-smear-positive case: A
person with at least one sputum smear positive for
acid fast bacilli (AFB) by fluorescent microscopy,
irrespective of culture results; (ii) Sputum-smear-
negative, culture-positive case: A person with sputum
smears negative on all specimens collected for AFB,
but at least one culture positive for Mycobacterium
tuberculosis.
X-ray abnormals: Chest X-ray was read as possible
or probable tuberculosis by two independent readers
with sputum negative by smear and culture.
Abacillary case: Of the X-ray abnormals, those who
are likely to break down to bacillary cases or
radiological progression  warranting initiation of anti-
TB treatment.
Extrapulmonary tuberculosis: Tuberculosis affecting
other than lung parenchyma.
The data used for the estimation of the burden of
disease, were obtained from three different sources -
(i) During 1999-2001, TRC undertook a large scale
community survey in a sub-district population of
Tiruvallur district in south India, to estimate the
prevalence of TB disease among the population aged
>15 yr, and an ARTI survey8. In the disease
prevalence survey, two screening tools namely,
symptom elicitation and chest radiography, were used
for the detection of cases. The adjusted prevalences
of smear-positive, smear-negative culture-positive and
X-ray abnormal cases were estimated. The ARTI was
estimated by the mirror image method10; (ii) Data on
the disease prevalence among children aged 0-14 yr
from a survey9 conducted by the NTI which was
correlated with the south zone ARTI of 1 per cent
(95% CI: 0.7-1.4%)7; and (iii) The ARTI estimates
from rural and urban areas obtained from the nation-
wide survey, conducted jointly by NTI and TRC7
during 2000-2003.
Data analysis: The burden of disease was estimated
as follows: the prevalence of disease corresponding
to 1 per cent ARTI in the Tiruvallur study was
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multiplied by the corresponding ARTI estimates from
the  nation-wide ARTI survey for the rural and urban
areas of the four survey zones to get the estimates of
the prevalence in the respective areas. These estimates
of prevalence were then multiplied by the adult
population in the respective areas, to obtain the
estimated number of prevalent cases. The prevalence
among children was estimated in the same way
assuming for an ARTI of 1 per cent as obtained from
the south zone5. The number of abacillary cases was
estimated assuming a breakdown of 30 per cent of
X-ray abnormals that required treatment11 and
extrapulmonary cases as 20 per cent of bacillary
cases. These estimates of bacillary, abacillary and
extrapulmonary cases were then combined to get the
national burden.
The rates of prevalence of smear-positive cases,
smear-negative culture-positive cases, and X-ray
abnormals were estimated after adjusting for those
not examined by X-ray and/or sputum examinations.
The 95 per cent  confidence intervals (CI) were
obtained for the burden estimates. The prevalence
based on the screening methods namely, symptom and
radiography screening among adults for smear-
positive cases, and smear-negative culture-positives
were 333 and 332 per 100,000, respectively. The
corresponding figures for prevalence based on
radiography alone were 282 and 266, respectively. The
prevalence rate of X-ray abnormals among adults was
2360 per 100,000. For children, the corresponding
figures were 26, 123 and 300 per 100,000,
respectively. The ARTI was estimated to be 2.0 per
cent  (95% CI: 1.7-2.3) by the mirror-image technique
for the age group of 1-9 yr.
Extrapolation of data: Based on the census of India-
1991 and 2001,  the population of India for 2000 was
taken to be 1005 million with 35 per cent of the total
population aged  0-14 yr. As there are no data available
on the prevalence of disease at the national level,
prevalence data among adults generated by the TRC
survey and that among children by NTI, were
extrapolated for the national estimation.
Results & Discussion
The estimated number of bacillary cases was 3.75
million (95% CI: 2.8-4.7), of which 1.7 million (95%
CI: 1.3-2.1) were smear-positive cases and 2.05 million
(95% CI: 1.5-2.6) smear-negative, culture-positive
cases (Table I). X-ray abnormals were estimated to
be 12.9 million (95% CI: 9.7-16.0). The number of
abacillary cases was estimated to be 3.9 million (30%
of 12.9 million X-ray abnormals) with 95 per cent  CI:
2.9 - 4.8 and that for extra-pulmonary cases was 0.8
million (20% of 3.8 million bacillary cases) with 95 per
cent CI: 0.6-0.9 giving a total burden of 8.5 million
with 95 per cent CI: 6.3-10.4 (Table II).
To get a direct estimate of burden of TB disease
in India, a large scale national survey would be
required. However, due to lack of recent data on the
nation-wide prevalence of disease, the estimated
burden of tuberculosis presented here was based
mainly on data generated from an area where
community disease and ARTI surveys are in progress,
and on estimates of ARTI in different parts of the
country from the recent nation-wide ARTI survey7.
There are inherent limitations in undertaking such an
exercise using the available data. However, despite
the limitations, we estimated that in the year 2000
there were 3.8 million bacillary cases and 12.9 million
X-ray abnormals.  All the X-ray abnormals estimated
here may not be bacillary cases and most of them
may not develop to active cases in future. The
question whether it would be correct to treat these
sputum-negative X-ray abnormals  assumes national
importance from burden estimation point of view. A
study11 conducted by NTI in 1975-76 followed up X-
ray abnormals for one year and found that about 30
per cent broke down either with bacillary disease or
radiological progression. Another study12 in Hong
Kong showed that confirmation of active disease
requiring treatment was obtained for 76 (42%) of the
181 X-ray abnormals during a 12 month period. About
30 per cent  of the X-ray abnormals had chest
symptoms in addition in the TRC series (unpublished
data). Considering all these factors, it was reasonable
to assume that 30 per cent  of the X-ray abnormals
at the time of the survey to be active cases of TB.
Thus, 30 per cent  of 12.9 million X-ray abnormals,
were likely to break down to bacillary cases or
progress radiologically requiring anti-TB treatment;
3.9 million (12.9 x 30%) of the X-ray abnormals were
alone considered to be abacillary cases. The number
of extrapulmonary cases was estimated to be 0.8
million of 3.8 million bacillary cases (20% of 3.8).
Thus, the burden of tuberculosis projected in the
country for the year 2000 was 8.5 million.
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In 1997, Dye  et al1 estimated the incidence of
TB in India to be 1.8 million (187 per 100,000
population) and arrived at the prevalence of TB (505
per 100,000) by multiplying the incidence by the
duration (2.7 yr) of the disease. On similar lines, the
estimated incidence for the year 2000 was 180 per
100,000 population13. These estimates were obtained
by reviewing data from notification of TB cases
without including X-ray abnormals and
extrapulmonary cases. From the 1955-58 NSS, based
on radiography alone as the screening tool, the
prevalence of bacteriologically positive cases was 400
per 100,000 population and that for X-ray abnormals
1600 per 100,000 population.  In 2000, an expert
committee convened at NTI, Bangalore by the GoI,
analyzed the data available at that time from
comparable studies, and estimated the burden in the
year 2000 as 4.32 million bacillary cases and 11 million
X-ray abnormals (unpublished data). The present
estimation is based on prevalence data generated from
using both symptom elicitation and chest radiography
for the diagnosis of tuberculosis cases and hence the
estimate is likely to be more accurate. The current
burden using chest radiography alone as the screening
method, and using the same methodology as in the
NSS, was estimated to be 320 bacillary cases per
100,000 population. The current estimates have taken
into account the population increase in the country
and the recent available prevalence data. As RNTCP
is showing remarkable success in terms of cure rate
and nation-wide coverage is planned for 2005, it is
expected that the burden of prevalent cases should
decrease considerably over a period of few years.
The current burden of TB in the country can be
compared with the burden in few years time, the long
term impact of the programme could be measured.
Our estimation has the following limitations: We
have assumed that the relationship between the ARTI
and the prevalence of disease was similar in all four
zones of the country and that TB control measures
and outcomes were similar across the country. The
latter assumption was probably reasonable because
only 180 million population were covered under the
DOTS-based RNTCP in January 2000. The age-sex
composition of the adults in the study population of
Tiruvallur was found to be similar to the general
population of India. So the burden of estimate is
unlikely to differ significantly from the present
estimate. On the whole we have not attempted to
estimate the burden of disease adjusting for age and
sex. The impact of HIV on the epidemic was not
considered separately. To the extent that HIV
contributes to transmission,  may be partly accounted
for by the impact on the ARTI. There is evidence
Table I. Zone-wise urban and rural populations and number of cases (in million)
Zone ARTI % Population Smear- Smear- Total bacillary X-ray
positive negative, cases abnormals
culture-positive
East - Rural 1.2 213.3 0.294 0.355 0.649 2.232
Urban 1.6 46.0 0.085 0.102 0.187 0.642
North - Rural 1.5 177.9 0.306 0.370 0.676 2.327
Urban 3.3 58.2 0.221 0.266 0.487 1.675
South - Rural 0.8 164.1 0.151 0.182 0.333 1.145
Urban 1.6 70.2 0.129 0.156 0.285 0.979
West - Rural 1.4 191.4 0.308 0.372 0.680 2.336
Urban 2.1 84.0 0.203 0.245 0.448 1.539
Total 1.5 1005.1 1.70 2.05 3.75 12.87
(95% CI) (1.28-2.11) (1.54-2.55) (2.82-4.66) (9.72-16.03)
ARTI, Annual risk of tuberculosis infection
Table II. Estimated burden of tuberculosis in India for the year
2000 (in million)
Type of case No. (95% CI)
Bacillary cases 3.8 (2.8-4.7)
Abacillary cases 3.9 (2.9-4.8)
Extrapulmonary cases 0.8 (0.6-0.9)
Total cases 8.5 (6.3-10.4)
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from Africa that the impact of HIV infection on
incidence is much greater than on prevalence14, thus
the methodology used here would lead to an
underestimate of TB incidence. However, the overall
prevalence of HIV in Tiruvallur is still less than 1 per
cent  (unpublished data) so, the effect is unlikely to
be substantial. Since the current estimate of the
incidence rate was not available and we could not
establish the relationship between ARTI and incidence
of smear-positive cases, we used the relationship
between ARTI and prevalence rates. Hence, the
possible errors in comparison of ARTI with the
prevalence of the disease have also not been
considered.
The present study provides a point-estimate for
the year 2000 and the impact of growing population
with passage of time is therefore not appropriate here.
This study is an exercise aimed at providing a rough
estimate for the programme manager. A mathematical
modeling might be needed to provide a range of
different estimates based realistic assumptions and
allowing impact of growing populations.
In conclusion, the burden of TB for the year 2000
was estimated to be 8.5 million (3.8 million bacillary
cases, 3.9 million abacillary cases and 0.8 million
extrapulmonary cases). These estimates provided
baseline information for advocacy,  planning resource
allocation and to measure the impact of TB control
activities in India in future.
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